For the quarter ending 2025-09-30, SYRA made $1,687,971 in revenue. -$225,902 in net income. Net profit margin of -13.38%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net revenues | 1,687,971 | 1,946,199 | 1,857,774 | 2,253,336 |
| Cost of services | 1,133,430 | 1,193,304 | 1,268,618 | 1,585,038 |
| Gross profit | 554,541 | 752,895 | 589,156 | 668,298 |
| Salaries and benefits | 336,390 | 326,354 | 507,207 | 594,738 |
| Professional services | 191,726 | 164,939 | 224,026 | 153,803 |
| Research and development expenses | 816 | 29,712 | 37,173 | 34,821 |
| Selling, general and administrative expenses | 252,384 | 289,070 | 287,287 | 288,305 |
| Depreciation | 5,396 | 5,978 | 6,797 | 25,541 |
| Total operating expenses | 786,712 | 816,053 | 1,062,490 | 1,097,208 |
| Operating loss | -232,171 | -63,158 | -473,334 | -428,910 |
| Interest income | 8,174 | 3,420 | 4,298 | 13,641 |
| Interest expense | 1,905 | 3,858 | 3,229 | 2,266 |
| Total other income (expense) | 6,269 | -438 | 1,069 | 11,375 |
| Net loss | -225,902 | -63,596 | -472,265 | -417,535 |
| Net loss per common share - basic | -0.02 | -0.01 | -0.04 | -0.06 |
| Net loss per common share - diluted | -0.02 | -0.01 | -0.04 | -0.06 |
| Weighted average common shares outstanding - basic | 11,939,169 | 11,939,169 | 11,587,058 | 7,264,768 |
| Weighted average common shares outstanding - diluted | 11,939,169 | 11,939,169 | 11,587,058 | 7,264,768 |
Syra Health Corp (SYRA)
Syra Health Corp (SYRA)